医学
小RNA
发病机制
低氧血症
急性呼吸窘迫
疾病
弥漫性肺泡损伤
背景(考古学)
生物信息学
重症监护医学
呼吸窘迫
肺
急性呼吸窘迫综合征
呼吸道疾病
免疫学
呼吸系统
机制(生物学)
炎症
炎症反应
间质性肺病
病危
肺病
全身炎症反应综合征
病理生理学
呼吸生理学
作者
Pengyu Wang,Dingyuan Lai,Litong Jin,Yi Xue
标识
DOI:10.3389/fimmu.2025.1570128
摘要
Acute lung injury (ALI) is characterized by a systemic and excessive inflammatory response triggered by various direct or indirect pathogenic factors, resulting in increased permeability of the alveolar-capillary membrane and the accumulation of fluid in the alveolar and interstitial spaces. Clinical symptoms include reduced lung compliance, respiratory distress, and severe hypoxemia that is difficult to manage. Acute respiratory distress syndrome (ARDS) represents a more severe form of ALI. The incidence of ALI/ARDS among critically ill patients is approximately 10.4%, with a mortality rate as high as 45%. MicroRNA (miRNA) is a small, non-coding RNA molecule approximately 22 nucleotides in length, which plays diverse roles in cellular functions and exerts a significant regulatory influence on disease progression. Research related to miRNAs, particularly in the context of ALI/ARDS, has increased in recent years due to its crucial involvement in the disease process. This article elucidates the molecular mechanisms of miRNA and outlines the current research advancements in ALI/ARDS, offering novel insights into the pathogenesis and potential clinical applications of this condition.
科研通智能强力驱动
Strongly Powered by AbleSci AI